Back to News
Market Impact: 0.55

Up 110% From 52-Week Lows, Celsius Stock Is Still A Buy

CELH
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsAnalyst EstimatesAnalyst InsightsProduct LaunchesMarket Technicals & FlowsInvestor Sentiment & Positioning
Up 110% From 52-Week Lows, Celsius Stock Is Still A Buy

Celsius (NASDAQ:CELH) shares have rallied 110% from their 52-week low to approximately $44.50, recovering from an earlier 56.7% decline this year. This significant rebound is driven by robust market share gains, successful product launches, and international expansion efforts. While Q1 revenue saw a temporary dip due to one-off factors like distributor incentive changes, the company's strong balance sheet and anticipated sales re-acceleration, supported by structural tailwinds in health-conscious consumption, position it for continued upside.

Analysis

Celsius (CELH) has demonstrated significant momentum, rallying 110% from its 52-week low of $21.10 to approximately $44.50, recovering from a sharp 56.7% decline earlier in 2024. This rebound is fundamentally supported by tangible business progress, including robust market share gains, successful product launches, and advancing international expansion efforts. Despite this positive traction, Q1 revenue experienced a notable decline, which is attributed to likely one-off factors such as modifications to distributor incentives, challenging year-over-year comparisons, and short-term promotional dynamics. The forward-looking outlook remains constructive, with expectations for sales to re-accelerate, underpinned by a pristine balance sheet and alignment with the structural consumer trend towards health-conscious products.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment